Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains?

Company Overview - Surgery Partners (SGRY) shares increased by 21.2% to close at $25.75, with trading volume significantly higher than usual [1] - The stock has seen a 3.3% gain over the past four weeks [1] Acquisition Proposal - Bain Capital Private Equity proposed a non-binding acquisition of all outstanding shares of Surgery Partners not already owned by them for$ 25.75 per share [2] Earnings Expectations - Surgery Partners is expected to report quarterly earnings of $0.40 per share, reflecting a year-over-year decline of 9.1% [3] - Revenue is projected to be$ 828.84 million, which is a 12.7% increase from the same quarter last year [3] Earnings Estimate Trends - The consensus EPS estimate for Surgery Partners has remained unchanged over the last 30 days [4] - A lack of trend in earnings estimate revisions typically correlates with stock price movements, indicating the need to monitor SGRY for potential future strength [4] Industry Context - Surgery Partners is part of the Zacks Medical Services industry, which includes other companies like Teladoc (TDOC) [4] - Teladoc's consensus EPS estimate has also remained unchanged at -$0.21, representing a 23.5% decline from the previous year [5]